Los Angeles Capital Management & Equity Research Inc. Buys 343,935 Shares of Nu Skin Enterprises, Inc. (NUS)

Los Angeles Capital Management & Equity Research Inc. lifted its stake in Nu Skin Enterprises, Inc. (NYSE:NUS) by 410.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 427,800 shares of the company’s stock after purchasing an additional 343,935 shares during the period. Los Angeles Capital Management & Equity Research Inc. owned about 0.77% of Nu Skin Enterprises worth $35,259,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Harvest Fund Management Co. Ltd boosted its holdings in Nu Skin Enterprises by 162.9% in the third quarter. Harvest Fund Management Co. Ltd now owns 1,291 shares of the company’s stock valued at $106,000 after purchasing an additional 800 shares during the period. Global X Management Co LLC boosted its holdings in Nu Skin Enterprises by 141.9% in the second quarter. Global X Management Co LLC now owns 1,732 shares of the company’s stock valued at $135,000 after purchasing an additional 1,016 shares during the period. First Hawaiian Bank purchased a new position in Nu Skin Enterprises in the third quarter valued at $165,000. Engineers Gate Manager LP purchased a new position in Nu Skin Enterprises in the third quarter valued at $204,000. Finally, Oppenheimer Asset Management Inc. purchased a new position in Nu Skin Enterprises in the second quarter valued at $210,000. Hedge funds and other institutional investors own 76.47% of the company’s stock.

NUS has been the subject of a number of recent research reports. Stifel Nicolaus upgraded Nu Skin Enterprises from a “sell” rating to a “hold” rating and lifted their target price for the company from $57.00 to $70.00 in a report on Thursday, August 2nd. They noted that the move was a valuation call. Jefferies Financial Group set a $98.00 target price on Nu Skin Enterprises and gave the company a “buy” rating in a report on Friday, August 3rd. Zacks Investment Research upgraded Nu Skin Enterprises from a “sell” rating to a “hold” rating and set a $95.00 target price for the company in a report on Monday, August 6th. Finally, DA Davidson initiated coverage on Nu Skin Enterprises in a report on Tuesday, October 9th. They issued a “buy” rating and a $92.00 target price for the company. One investment analyst has rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating to the company. Nu Skin Enterprises has an average rating of “Buy” and a consensus price target of $86.29.

Shares of NYSE NUS opened at $72.57 on Wednesday. The stock has a market cap of $3.98 billion, a price-to-earnings ratio of 22.47, a price-to-earnings-growth ratio of 1.75 and a beta of 1.04. The company has a quick ratio of 1.19, a current ratio of 1.82 and a debt-to-equity ratio of 0.46. Nu Skin Enterprises, Inc. has a 1 year low of $59.91 and a 1 year high of $88.68.

In other Nu Skin Enterprises news, insider Joseph Y. Chang sold 10,600 shares of Nu Skin Enterprises stock in a transaction dated Thursday, August 9th. The stock was sold at an average price of $82.13, for a total transaction of $870,578.00. Following the completion of the sale, the insider now directly owns 63,416 shares of the company’s stock, valued at approximately $5,208,356.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel D Matthew Dorny sold 3,750 shares of Nu Skin Enterprises stock in a transaction dated Friday, August 10th. The stock was sold at an average price of $81.84, for a total value of $306,900.00. Following the sale, the general counsel now directly owns 33,871 shares of the company’s stock, valued at $2,772,002.64. The disclosure for this sale can be found here. Insiders have sold a total of 19,350 shares of company stock valued at $1,582,678 over the last ninety days. 3.00% of the stock is owned by company insiders.

ILLEGAL ACTIVITY WARNING: This news story was reported by WKRB News and is the sole property of of WKRB News. If you are viewing this news story on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this news story can be accessed at https://www.wkrb13.com/2018/11/07/los-angeles-capital-management-equity-research-inc-buys-343935-shares-of-nu-skin-enterprises-inc-nus.html.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.

Read More: Market Capitalization

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply